Hypobaric hypoxia: A method for testing bioreductive drugs in vivo (Q41812668)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1612955%20AND%20SRC:MED&resulttype=core&format=json

22 September 2019

title

Hypobaric hypoxia: a method for testing bioreductive drugs in vivo (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1612955%20AND%20SRC:MED&resulttype=core&format=json

22 September 2019

Hypobaric hypoxia: A method for testing bioreductive drugs in vivo (English)

1 reference

https://api.crossref.org/works/10.1016/0360-3016(92)90010-F

15 October 2022

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1612955

15 October 2022

1 reference

https://api.crossref.org/works/10.1016/0360-3016(92)90010-F

15 October 2022

3

M. P. MacManus

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1612955

15 October 2022

author name string

J. J. McAleer

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1612955

15 October 2022

S. R. McKeown

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1612955

15 October 2022

T. R. Lappin

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1612955

15 October 2022

J. M. Bridges

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1612955

15 October 2022

language of work or name

English

0 references

publication date

1 January 1992

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1612955%20AND%20SRC:MED&resulttype=core&format=json

full work available at URL

22 September 2019

https://api.elsevier.com/content/article/PII:036030169290010F?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0360-3016(92)90010-F

https://api.elsevier.com/content/article/PII:036030169290010F?httpAccept=text/plain

15 October 2022

1 reference

https://api.crossref.org/works/10.1016/0360-3016(92)90010-F

International Journal of Radiation Oncology Biology Physics

15 October 2022

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1612955%20AND%20SRC:MED&resulttype=core&format=json

22 September 2019

volume

23

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1612955%20AND%20SRC:MED&resulttype=core&format=json

22 September 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1612955%20AND%20SRC:MED&resulttype=core&format=json

22 September 2019

page(s)

551-555

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1612955%20AND%20SRC:MED&resulttype=core&format=json

Comparison between X-rays and SR 4233 for cytotoxicity and repair of potentially lethal damage in human cells

22 September 2019

cites work

3

1 reference

https://api.crossref.org/works/10.1016/0360-3016(92)90010-F

Interleukin-1α-induced Tumour Pathophysiologies Can Be Exploited with Bioreductive Alkylating Agents

15 October 2022

4

1 reference

https://api.crossref.org/works/10.1016/0360-3016(92)90010-F

Bioreductive drugs and the selective induction of tumour hypoxia

15 October 2022

5

1 reference

https://api.crossref.org/works/10.1016/0360-3016(92)90010-F

Potentiation of RSU-1069 tumour cytotoxicity by 5-hydroxytryptamine (5-HT).

15 October 2022

6

1 reference

https://api.crossref.org/works/10.1016/0360-3016(92)90010-F

Effect of the manipulation of oxyhemoglobin status by BW12C on tumor thermosensitivity and on blood flow in tumor and normal tissues in mice.

15 October 2022

7

1 reference

https://api.crossref.org/works/10.1016/0360-3016(92)90010-F

Synthesis and evaluation of alpha-[[(2-haloethyl)amino]methyl]-2- nitro-1H-imidazole-1-ethanols as prodrugs of alpha-[(1-aziridinyl)methyl]-2- nitro-1H-imidazole-1-ethanol (RSU-1069) and its analogues which are radiosensitizers and bioreductively ac

15 October 2022

8

1 reference

https://api.crossref.org/works/10.1016/0360-3016(92)90010-F

The effect of hypobaric hypoxia on misonidazole binding in normal and tumour-bearing mice.

15 October 2022

10

1 reference

https://api.crossref.org/works/10.1016/0360-3016(92)90010-F

Tumor hypoxia: its impact on cancer therapy

15 October 2022

11

1 reference

https://api.crossref.org/works/10.1016/0360-3016(92)90010-F

The dynamics of tumor cords in an irradiated mouse mammary carcinoma with a large hypoxic cell component.

15 October 2022

12

1 reference

https://api.crossref.org/works/10.1016/0360-3016(92)90010-F

The differential hypoxic cytotoxicity of bioreductive agents determined in vitro by the MTT assay

15 October 2022

13

1 reference

https://api.crossref.org/works/10.1016/0360-3016(92)90010-F

Reduction of nitromin to nitrogen mustard: unscheduled DNA synthesis in aerobic or anaerobic rat hepatocytes, JB1, BL8 and Walker carcinoma cell lines.

15 October 2022

15

1 reference

https://api.crossref.org/works/10.1016/0360-3016(92)90010-F

SR-4233: a new bioreductive agent with high selective toxicity for hypoxic mammalian cells

15 October 2022

16

1 reference

https://api.crossref.org/works/10.1016/0360-3016(92)90010-F

Structure-activity relationships for benzotriazine di-N-oxides

15 October 2022

17

1 reference

https://api.crossref.org/works/10.1016/0360-3016(92)90010-F

15 October 2022

Identifiers

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1612955%20AND%20SRC:MED&resulttype=core&format=json

22 September 2019

1 reference